Loading…
Based on limited metadata from an FDA Warning Letter issued to Essential Pharmaceutical Corp on September 3, 2020, the agency identified compliance concerns related to drug manufacturing or distribution operations. Without access to the full letter text or specific subject line details, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product oversight and enforcement authority. Additional context from the complete warning letter would be needed to identify the specific regulatory violations and remedial actions required.